Connective Portfolio Management LLC Takes $849,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Connective Portfolio Management LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,829 shares of the financial services provider’s stock, valued at approximately $849,000. iShares Biotechnology ETF comprises about 0.9% of Connective Portfolio Management LLC’s portfolio, making the stock its 26th biggest position.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Blue Fin Capital Inc. raised its holdings in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares in the last quarter. Security National Bank of SO Dak grew its stake in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares in the last quarter. Main Street Financial Solutions LLC increased its holdings in shares of iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares during the last quarter. Perkins Coie Trust Co raised its position in shares of iShares Biotechnology ETF by 0.3% during the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after buying an additional 83 shares in the last quarter. Finally, HCR Wealth Advisors increased its stake in iShares Biotechnology ETF by 0.6% in the second quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after acquiring an additional 83 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.1 %

IBB stock traded down $0.14 during mid-day trading on Wednesday, hitting $142.86. 78,110 shares of the stock were exchanged, compared to its average volume of 1,479,026. The business has a fifty day moving average price of $145.27 and a 200 day moving average price of $139.22. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.